Key points are not available for this paper at this time.
We successfully demonstrated particular exosomal miRNAs that may serve as future biomarkers for CAD.
Chang et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: